EP2649544A1 - Systems and methods for automatically displaying patterns in biological monitoring data - Google Patents
Systems and methods for automatically displaying patterns in biological monitoring dataInfo
- Publication number
- EP2649544A1 EP2649544A1 EP11794044.5A EP11794044A EP2649544A1 EP 2649544 A1 EP2649544 A1 EP 2649544A1 EP 11794044 A EP11794044 A EP 11794044A EP 2649544 A1 EP2649544 A1 EP 2649544A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- segments
- interest
- processors
- automatically
- collection system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
Definitions
- the present specification generally relates to systems and methods for automatically displaying patterns in biological monitoring data and, more specifically, to systems and methods for automatically displaying patterns in glucose monitoring data.
- Biological monitoring data can provide health care providers (HCPs) and patients with ambulatory data that can be utilized to treat and/or manage a medical condition related to biological data.
- HCPs health care providers
- CGM continuous glucose monitoring
- PwDs person with diabetes
- the glucose data can be indexed to time and/or any other method suitable to correlate the glucose data to contextual data such as, for example, meal tags, time of day, day- of-the-week, and the like.
- HCPs and/or PwDs can identify patterns in the glucose data by sorting based upon the contextual data.
- contextual data is often unavailable.
- HCPs and/or PwDs may not have enough information available to effectively and efficiently make use of all of the available contextual data, i.e., available data patterns can be overlooked.
- a collection system for automatically displaying patterns in glucose data may include one or more processors, an electronic display and machine readable instructions.
- the electronic display can be communicatively coupled to the one or more processors.
- the machine readable instructions that can be executed by the one or more processors.
- the machine readable instructions can cause the one or more processors to receive a glucose data signal indicative of ambulatory glucose levels sampled over time.
- the one or more processers can divide the glucose data signal into segments of interest.
- the one or more processers can transform, automatically, each of the segments of interest into a set of features according to a mathematical algorithm.
- the one or more processers can cluster, automatically, the segments of interest into groups of clustered segments according to a clustering algorithm.
- the segments of interest can be grouped in the groups of clustered segments based at least in part upon the set of features.
- a cluster center can be associated with one of the groups of clustered segments.
- the cluster center can be based upon a mean the one of the groups of clustered segments.
- the one or more processers can present, automatically, the cluster center on the electronic display.
- a method for automatically displaying patterns in biological monitoring data may include receiving biological data indicative of ambulatory biological information sampled over time from one or more subjects.
- the biological data may include a time index.
- the biological data can be divided into segments of interest according to the time index.
- Each of the segments of interest can be transformed, automatically with one or more processors, into a set of features according to a mathematical algorithm.
- the segments of interest can be clustered, automatically with one or more processors, into groups of clustered segments according to a clustering algorithm.
- the clustering algorithm can calculate a distance metric based at least in part upon the set of features of each of the segments of interest such that similar segments of interest are grouped in one of the groups of clustered segments.
- the clustering algorithm can calculate a cluster center that is associated with one of the groups of clustered segments.
- the cluster center can be based upon a mean of the one of the groups of clustered segments.
- the cluster center can be presented, automatically with the one or more processors, with a human machine interface.
- FIG. 1 schematically depicts a system for automatically displaying patterns in biological data according to one or more embodiments shown and described herein;
- FIG. 2 schematically depicts a display provided with a human machine interface according to one or more embodiments shown and described herein;
- FIG. 3 schematically depicts a display provided with a human machine interface according to one or more embodiments shown and described herein;
- FIG. 4 schematically depicts a pattern enhancement algorithm according to one or more embodiments shown and described herein;
- FIG. 5 schematically depicts biological data and segments of interest according to one or more embodiments shown and described herein;
- FIG. 6 schematically depicts a display provided with a human machine interface according to one or more embodiments shown and described herein;
- FIG. 7 schematically depicts a display provided with a human machine interface according to one or more embodiments shown and described herein;
- FIG. 8 schematically depicts a pattern enhancement algorithm according to one or more embodiments shown and described herein.
- FIG. 9 graphically depicts the output from an optimizer according to one or more embodiments shown and described herein.
- signal means a waveform (e.g., electrical, optical, magnetic, mechanical or electromagnetic), such as DC, AC, sinusoidal-wave, triangular- wave, square- wave, vibration, and the like, capable of traveling through a medium.
- waveform e.g., electrical, optical, magnetic, mechanical or electromagnetic
- the phrase "communicatively coupled” means that components are capable of exchanging data signals with one another such as, for example, electrical signals via conductive medium, electromagnetic signals via air, optical signals via optical waveguides, and the like.
- the term "sensor,” as used herein, means a device that measures a physical quantity and converts it into a data signal, which is correlated to the measured value of the physical quantity, such as, for example, an electrical signal, an electromagnetic signal, an optical signal, a mechanical signal, and the like.
- continuous means substantially uninterrupted for a period of time.
- continuous data can be data that is sampled in a substantially uninterrupted manner for a period of time, i.e., the data can be sampled at a set and/or varying sample rate with minimal interruption.
- glucose meter means any device to determine continuously or discontinuously a glucose level in a body fluid such as blood or interstitial fluid. Such devices are well known for a person having ordinary skills in the art.
- medication delivery device means e.g. an insulin pump, or patch pump, an insulin pen or a glucose delivery device, in particular realized as a pump or combinations of insulin and glucose delivery systems. Possible is also a device to deliver another medication to a person wherein the medication influences the person's glucose level.
- FIG. 1 generally depicts one embodiment of a system for automatically displaying patterns in biological data (e.g., glucose data).
- the system generally comprises one or more processors, a human machine interface communicably coupled to the one or more processors, and machine readable instructions that are executed by the one or more processors to automatically display patterns in biological data.
- a human machine interface communicably coupled to the one or more processors
- machine readable instructions that are executed by the one or more processors to automatically display patterns in biological data.
- the system 100 for automatically displaying patterns in biological data comprises one or more processors 1 10 for executing machine readable instructions and automatically directing components communicatively coupled (generally indicated in FIG. 1 as double arrowed lines) to the one or more processors 1 10.
- the one or more processors 1 10 can optionally be communicatively coupled to a memory 1 12 for storing machine readable instructions.
- the one or more processors 1 10 may be a controller, an integrated circuit, a microchip, a computer, or any other computing device capable of executing machine readable instructions.
- the memory 1 12 may be RAM, ROM, a flash memory, a hard drive, or any device capable of storing machine readable instructions.
- the one or more processors 1 10 may be integral with a single component of the system 100. However, it is noted that the one or more processors 1 10 may be separately located within discrete components such as, for example, a glucose meter, a medication delivery device, a mobile phone, a portable digital assistant (PDA), a mobile computing device such as a laptop, a tablet, or a smart phone, a desktop computer, or a server e.g. via a cloud or web based technologies and communicatively coupled with one another without departing from the scope of the present disclosure.
- a glucose meter such as a glucose meter, a medication delivery device, a mobile phone, a portable digital assistant (PDA), a mobile computing device such as a laptop, a tablet, or a smart phone, a desktop computer, or a server e.g. via a cloud or web based technologies and communicatively coupled with one another without departing from the scope of the present disclosure.
- PDA portable digital assistant
- such a device may include a touch screen and the computing ability to run computational algorithms and/or processes, such as those disclosed herein, and applications, such as an electronic mail program, a calendar program for providing a calendar, as well as provide cellular, wireless, and/or wired connectivity and one or more of the functions of a blood glucose meter, a digital media player, a digital camera, a video camera, a GPS navigation unit, and a web browser that can access and properly display web pages.
- the system 100 may include a plurality of components each having one or more processors 1 10 that are communicatively coupled with one or more of the other components.
- the systems 100 may utilize a distributed computing arrangement to perform any or the machine readable instructions described herein.
- the systems 100 further comprises a human machine interface 1 14 communicatively coupled to the one or more processors 1 10 for receiving signals from the one or more processors 1 10 and presenting graphical, textual and/or auditory information.
- the human machine interface may include an electronic display such as, for example, a liquid crystal display, thin film transistor display, light emitting diode display, a touch screen, or any other device capable of transforming signals from a processor into an optical output, or a mechanical output, such as, for example, a speaker, a printer for displaying information on media, and the like.
- Embodiments of the present disclosure comprise machine readable instructions that includes logic or an algorithm written in any programming language of any generation (e.g., 1 GL, 2GL, 3GL, 4GL, or 5GL) such as, e.g., machine language that may be directly executed by the processor, or assembly language, object-oriented programming (OOP), scripting languages, microcode, etc., that may be compiled or assembled into machine readable instructions and stored on a machine readable medium.
- the logic or algorithm may be written in a hardware description language (HDL), such as implemented via either a field-programmable gate array (FPGA) configuration or an application-specific integrated circuit (ASIC), and their equivalents.
- HDL hardware description language
- FPGA field-programmable gate array
- ASIC application-specific integrated circuit
- machine readable instructions may be implemented in any conventional computer programming language, as pre-programmed hardware elements, or as a combination of hardware and software components.
- machine readable instructions can be distributed over various components that are communicatively coupled such as, for example, via wires, via a wide area network, via a local area network, via a personal area network, and the like.
- any components of the system 100 can transmit signal over the Internet or World Wide Web).
- the system 100 may optionally include a biological sensor 1 16 communicatively coupled to the one or more processors 1 10 for providing biological data indicative of properties of an analyte.
- the biological sensor 1 16 can be a glucose sensor configured to detect glucose levels (e.g., glucose concentrations) when placed just under the skin of a PwD.
- the biological sensor 1 16 can be a disposable glucose sensor that is worn under the skin for a few days until replacement is needed.
- the biological sensor 1 16 can be communicatively coupled with the one or more processors 1 10, which can be located within various discrete components.
- the biological sensor 1 16 can be communicatively coupled with, for example, a smart glucose meter, or a medication delivery device and can provide ambulatory CGM data, i.e., glucose data that is sampled continuously throughout the lifetime of the sensor. It is noted that, while the embodiments described herein make reference to blood glucose, the biological sensor 1 16 can be any sensor that detects biological data related to the treatment and/or management a medical condition related biological data. Furthermore, it is noted that the embodiments described herein can utilize data provided by any discrete component communicatively coupled to the one or more processors 1 10.
- the biological data can be stored and provided to the one or more processors 1 10 after a delay of any duration, i.e., the embodiments described herein can be performed offline. Accordingly, the biological data can be aggregated from a population of multiple test subjects. [0032] According to the embodiments described herein, the one or more processors
- the biological data can be combined with continuous data, semi-continuous data, and discrete data from any component
- the one or more processors 1 10 can execute machine readable instructions to display an Ambulatory Glucose Profile (AGP), or Modal Day on the human machine interface 1 14.
- a Modal Day plot 120 can display multiple periods of time indexed glucose data normalized to a specific time of day (e.g., 5:00) and plotted with increasing time along the horizontal axis. Accordingly, the Modal Day plot 120 can simultaneously display multiple days of glucose data (24 hour period) with each day of glucose data in the Modal Day plot 120 corresponding to a Modal Day data curve 122 (generally indicated in FIG. 2 as a dashed line).
- the Modal Day data curves 122 can be statistically evaluated to identify any patterns that may exist in the glucose data. For example, the median 124 can be calculated and overlaid upon the Modal Day data curves 122 in the Modal day plot 120. Similarly, the third quartile 126 and the first quartile 128 can be calculated and overlaid upon the data curves 122. In further embodiments, the Modal day plot 120 can include additional statistics such as, for example, the mean and standard deviation for the time period. Alternatively or additionally, the Modal Day plot 120 may include the range of the glucose data, maximum of the glucose data, minimum of the glucose data, or raw data for each time period.
- the Modal Day plot 120 can be utilized to automatically display a dominant glucose pattern 129.
- the dominant glucose pattern 129 can be seen from 7:00 to about 13:00 and may represent a meal rise due to breakfast, for example. Accordingly, a PwD may be able to adjust behavior by identifying the dominant glucose pattern 129 that is displayed in the Modal Day plot 120.
- the remaining portions of data curves 122 fail to conform to any distinct pattern. Accordingly, the Modal Day plot 120 does not display any pattern in the portion of the time period falling outside of the dominant glucose pattern 129.
- the Modal Day plot 120 can obscure the display of the data curves 122 by overlaying data. Moreover, in some embodiments, only reporting statistics are displayed.
- the one or more processors 1 10 can execute machine readable instructions to display a timeline grid 140 on the human machine interface 1 14.
- the timeline grid 140 can simultaneously display multiple data curves 122 each displayed in a separate section (e.g., Day 1 , Day 2, Day
- Patterns are displayed and can be linked together.
- the displayed timeline grid 140 can be visually scanned.
- Each day that exhibits similar patterns can be linked, i.e., the corresponding portions of the data curves 122 can be selected and linked together in the memory 1 12. For example, Day 1 , Day 2, Day
- the timeline grid 140 can be utilized to display glucose data for a single sensor lifetime such as, for example, less than or equal to about nine days, or from about three days to about seven days. As the number of time periods displayed in the timeline grid 140 increases, the effectiveness of the timeline grid 140 for displaying patterns can decrease and patterns may be missed.
- the one or more processors 1 10 can execute machine readable instructions to execute a pattern enhancement algorithm 150 to automatically enhance patterns that may exist within biological data such as blood glucose data or CGM data. As is described in greater detail herein, once the patterns in the biological data are enhanced, the patterns in the biological data can automatically be displayed data on the human machine interface 1 14.
- the pattern enhancement algorithm 150 generally enhances data patterns by clustering similar biological outcomes, i.e., glucose values, to identify the inputs that may have caused the biological response.
- the pattern enhancement algorithm 150 comprises a process 152 for receiving biological data indicative of ambulatory biological information sampled over time from one or more subjects.
- the biological data 50 can include a time index 52 that is suitable to associate the biological data 50 with the time and/or date that the ambulatory biological information was sampled such as, for example, day, month, hour, minute, second, and the like.
- each instance of the biological data 50 can be associated with a time and a date indicative of the time and date that the ambulatory biological information was sampled.
- the pattern enhancement algorithm 150 can be utilized to enhance patterns that exist in any combination of continuous data, semi- continuous data and/or discrete data.
- Sources of semi-continuous data may include, for example, medication delivery device infusion profiles, bolus profiles, energy expenditure measurements, heart-rate movement, or any other data related to behaviors that may influence the health of a PwD.
- Sources of discrete data may include, for example, data tags, day of the week, month, season, sensor production lot number, insulin lot number, pump reusable lot numbers, or any other data or metadata related to behaviors that may influence the health of a PwD.
- the pattern enhancement algorithm 150 can also receive any other type continuous data, semi-continuous data and/or discrete data at process 152.
- the pattern enhancement algorithm 150 comprises a process 154 for segmenting data.
- the biological data 50 can be divided into segments of interest 56 according to the time index 52.
- the segments of interest 56 can each be a time window of data that corresponds to a predetermined duration, a predetermined start time, a predetermined end time or combinations thereof.
- the biological data 50 can be divided into segments of interest 56 that each correspond to a twenty-four hour day with a common start and end time.
- the biological data 50 can be divided into segments of interest 56 that each corresponds to a four hour time period or six hour time period of data to, for example, segment postprandial glucose profiles.
- the biological data 50 can be divided into segments of interest 56 that each corresponds to eight hour time period or ten hour time period of data to, for example, segment nocturnal glucose profiles.
- biological data 50 can be divided into segments of interest
- the segments of interest 56 can be tailored to a length of time that corresponds to any known biological process such as, for example, glucose response to a correction bolus, periods of exercise, glucose response after exercise, postprandial, before, during and/or after a therapy change and the like. Accordingly, although the embodiments described herein may utilize twenty-four hour time periods, other segments of time may be used without deviating from the scope of the disclosure. Moreover, it is noted that each of the segments of interest 56 can be separate (no duplicated data) or overlap. The segments of interest 56 may be selected based upon a uniform start time (e.g., 5 AM each day) or may be selected based on a contextual tag, or event, such as, for example, a meal tag or bolus event. When the biological data 50 is provided through CGM, the segments of interest 56 may contain raw continuous glucose measurements or the filtered signal along with additional relevant contextual data.
- a uniform start time e.g., 5 AM each day
- a contextual tag, or event such as, for example
- each of the segments of interest 56 can be transformed automatically into a set of features that is a reduced representation of the segments of interest 56 according to a mathematical algorithm.
- the mathematical algorithm can be any algorithm that extracts relevant information from the segments of interest 56 in order to perform the pattern recognition.
- the mathematical algorithm can be, for example, a Principal Component Analysis (PCA), a Kernel PCA, a wavelet analysis, a frequency analysis, or any other algorithm suitable to extract meaningful features.
- the set of features can be extracted from any combination of continuous data, semi-continuous data and/or discrete data.
- a set of features extracted from biological data 50 can be supplemented with discrete data, i.e., discrete data can be appended directly to calculated vectors.
- the set of features can be utilized by a distance metric to identify and enhance patterns in the biological data 50.
- the pattern enhancement algorithm 150 further comprises a process 158 for determining a distance metric.
- the distance metric can be any function capable of indicating the degree of similarity between each of the segments of interest 56.
- the function for determining the distance metric between each of the segments of interest 56 can be applied to the set of features of the segments of interest 56.
- the distance metric can be calculated as the sum of squared distance between the set of features of the segments of interest 56.
- functions for determining distance metrics include, but are not limited to, the sum of absolute distance, Mahalanobis distance, Manhattan distance, maximum norm, or any other common metrics known for evaluating sets of features.
- the distance metric may be determined based upon processed or filtered biological data (e.g., calibrated and filtered glucose data). The distance metric may also be calculated based upon the raw biological data.
- the distance metric may be calculated from the biological data 50 alone.
- the distance metric may be based on the distance between contextual data and/or contextual data tags.
- the distance metric may be calculated from CGM data and carbohydrate intake located near a specific insulin tag.
- the distance metric may be based upon the entire segment of interest, or a subset of the segment of interest. Accordingly, the distance metric and the set of features can be used by the pattern enhancement algorithm 150 to group individual segments of interest 56.
- the pattern enhancement algorithm 150 comprises a process 160 for clustering the segments of interest 56.
- a clustering algorithm can be applied automatically to cluster the segments of interest 56 into groups of clustered segments. Once clustered, similar segments of interest 56 are grouped in each the clustered segments. Accordingly, the groups of clustered segments enhance and identify patterns that exist within the data.
- the clustering algorithm can determine both the number of clusters and the segments of interest 56 that are assigned to each cluster based upon the distance metric.
- the clustering algorithm used may include functions for determining the number of clusters such as, for example, a Schwarz Criterion, a Bayesian Information Criterion, an Akaike
- the clustering algorithm used may include functions for assigning segments of interest 56 to cluster such as, for example, K-means, Hierarchical clustering (using either an agglomerative or divisive method or some combination of both), Gaussian mixture modeling, Normalized Cuts, or other any clustering algorithm. It is noted, that the example described below utilizes for K-means clustering, but other clustering algorithms may be utilized without deviating from the scope of the present disclosure.
- the pattern enhancement algorithm 150 may comprise a process 162 for ranking the groups of clustered segments.
- the groups of clustered segments can be associated with an importance ranking based on the number of segments in the group.
- the importance ranking can also be based upon the occurrence of an event such as, for example, hypoglycemia or hyperglycemia.
- a group of clustered segments can be associated with a relatively high importance ranking, compared to other groups of clustered segments, when the group includes a larger number of clustered segments, which can be indicative of a common behavior, than the other groups and is coincident with one or more instances of hypoglycemic events or hyperglycemic events.
- a group of clustered segments associated with a relatively high importance ranking can be indicative of behavior that needs to be addressed by the HCP or PwD. Accordingly, the groups of clustered segments clusters can be ranked based on the need for the HCP to adjust therapy or provide education to address the problem.
- the group of clustered segments can also be associated with dates to identify patterns that can occur on regular basis such as, for example, weekly, weekday vs. weekend, workday vs. non-workday, monthly or seasonally.
- the clustered segments can be aggregated based upon discrete data, for example, sensor production lot numbers, insulin lot numbers, or pump reusable lot numbers in order to help identify potential manufacturing defects.
- the patterns in the biological data can automatically be displayed on the human machine interface 1 14 by the one or more processors 1 10.
- the displayed clustered segments enhance the patterns that exist in the data and that may have been obscured.
- a user such as a HCP or a PwD can more readily identify patterns in the biological data.
- the mean of each group of clustered segments can be displayed automatically on the human machine interface 1 14.
- a first cluster center 130 corresponds to the mean of a first group of clustered segments
- a second cluster center 132 corresponds to the mean of a second group of clustered segments
- a third cluster center 134 corresponds to the mean of a third group of clustered segments
- a third cluster center 136 corresponds to the mean of a fourth group of clustered segments.
- the biological data may be summarized by only displaying the cluster centers 130, 132, 134, 136, which enhance the patterns that exist within the biological data.
- each of the cluster centers 130, 132, 134, 136 can be indicative of each of their importance ranking.
- the width of the cluster centers 130, 132, 134, 136 can be proportional to the number of segments included in the cluster.
- the width of the first cluster center 130, depicted in FIG. 6, indicates that the first group of clustered segments includes the highest number of clustered segments.
- the width of the second cluster center 132 indicates that the second group of clustered segments includes the second highest number of clustered segments
- the width of the third cluster center 134 indicates that the third group of clustered segments includes the third highest number of clustered segments
- the width of the fourth cluster center 136 indicates that the fourth group of clustered segments includes the lowest number of clustered segments. Accordingly, the displayed line width of each of the cluster centers 130, 132, 134, 136 can enhance consistent behaviors with relatively thick lines and outlier behaviors with relatively thin lines.
- cluster centers 130, 132, 134, 136 can be color coded according to importance rankings.
- Summary statistics may also be calculated for each group of clustered segments and automatically displayed on the human machine interface 1 14 by the one or more processors 1 10.
- the summary statistics may include the mean, median, standard deviation, mean absolute difference, range, quartiles or any other suitable statistics.
- the statistics may also include percentage of time in hyperglycemia, percentage of time within a target range, percentage of time below a threshold, or percentage of time above a specific threshold, for example.
- Summary statistics may also include parameters based on the number of groups that represent the biological data, the number of data segments in each group, or any other parameters related to the distribution of data segments within the groups of clustered segments.
- the summary statistics may be used as metrics to characterize the state of the PwD as well as indicators for potential therapy adjustments.
- regions of importance such as, for example, hyperglycemia, hypoglycemia, glucose target ranges, and the like can be displayed automatically on the human machine interface 1 14.
- a hypoglycemia threshold 138 and a target glucose concentration range 139 can be displayed on the human machine interface 1 14.
- the human machine interface 1 14 can also display contextual data associated with the clustered data segments such as, for example, meal tags, carbohydrate intake, insulin injections, or other relevant contextual data. It is noted that, while FIGS. 6 and 7 only depict the cluster centers, the cluster centers can be overlaid upon curves indicative of the clustered segments and/or the segments of interest.
- a calendar 20 can also be displayed by the human machine interface 1 14 to identify weekly or monthly patterns.
- the calendar 20 can be coded to indicate the dates that correspond to cluster centers 130, 132, 134, 136.
- Each code can be a color, a gradient, a shape, an alphanumeric, or any other visual indicator sufficient to distinguish the cluster code from other objects displayed by the human machine interface 1 14.
- dates coded with a first cluster code 30 include one or more clustered segments that correspond to the first cluster segment 130
- dates coded with a second cluster code 32 include one or more clustered segments that correspond to the second cluster center 132
- dates coded with a third cluster code 34 include one or more clustered segments that correspond to the first cluster segment 134
- dates coded with a fourth cluster code 36 include one or more clustered segments that correspond to the fourth cluster center 136.
- the calendar 20 can be provided with cluster codes to display the similarity between the clustered segments for the dates on the calendar 20.
- entries from calendar software such as Microsoft Outlook® or Google Calendar® can be imported and displayed with the calendar 20 to help identify behavior patterns that may be causes for the glucose patterns.
- the data from the clustered segments may be exported to a format so that it can be imported into calendar software.
- the calendar 20 can indicate visually missed events such as, for example, insulin boluses, activities or meals.
- the one or more processors 1 10 can accept input indicative of a selection made by a user.
- the one or more processors 1 10 can receive a selection signal indicative of the selection of a date on the calendar 20.
- the one or more processors 1 10 can respond to the selection signal by displaying the segments of interest that were sampled on the corresponding date.
- the one or more processors 1 10 can receive a cluster signal indicative of the selection of cluster center or code on the calendar 20 corresponding to a cluster center.
- the one or more processors 1 10 can respond to the cluster signal by displaying the clustered segments that are associated with the cluster center.
- an exemplary pattern enhancement algorithm 200 was executed by a processor to automatically group a CGM data indicative of ambulatory glucose levels sampled over time into groups of clustered segments.
- Filtered CGM data were received by the processor and segmented into segments of interest.
- Each segment of interest was selected to begin at 5:00 AM, so that the overnight data would remain continuous, and was of substantially equal length (about 24 hours).
- a set of features was extracted from each of the segments of interest.
- each of the segments of interest were compressed from vectors having a length of about 1440 (number of minutes in a day) into vectors having a length of about 20 by using the first 20 Eigenvectors.
- the exemplary pattern enhancement algorithm 200 included an iterative - means algorithm for clustering and utilized a Schwarz Criterion to determine the number of groups of clustered segments.
- the exemplary pattern enhancement algorithm 200 was initialized to perform a first iteration with the number of clusters k equal to 1.
- the cluster centers were calculated for the number of clusters k.
- the segments of interest were assigned to the groups at process 206.
- the cluster centers were recalculated using the groups of segmented clusters at process 208.
- a stability check was performed. When the solutions for K-means algorithm failed to converge, process 206 was repeated.
- process 212 was performed to determine the Schwartz Criterion. After process 212, process 204 was repeated for a predetermined number of iterations and the groups of clustered segments corresponding to the minimum Schwartz criterion was selected as the final result.
- the output from the Schwarz Criterion 224 is graphically depicted.
- the number of clusters was evaluated by using the Schwarz Criterion 224, which added a penalty term 222 to the optimization equation that was be based on the number of groups of clustered segments.
- n number of data points in X, the number of observations
- m the number of dimensions
- ⁇ a tuning parameter to adjust the balance between the distance based metric and the penalty term.
- the number of groups of clustered segments were determined by combining the quality metric 220 which measures how well the clustered segments fit the segments of interest with a penalty term 222 that penalizes based, in part, on the number of groups of clustered segments.
- Quality refers to the value of dist(X k , ⁇ X ⁇ k ) and "Penalty” refers to
- the minimum value 226 for the Schwarz Criterion 224 occurred when six groups of clustered segments were used.
- the embodiments described herein can be utilized to cluster data and automatically display cluster centers such that patterns that exist within the larger set of data are enhanced.
- the displayed cluster centers can allow patterns, sub-patterns, or behaviors to easily be identified. Accordingly, the displayed cluster centers can enhance and identify information that may otherwise be averaged out or obscured, e.g., when combining the multiple days of data into the AGP or modal day.
Landscapes
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Data Mining & Analysis (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Databases & Information Systems (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42080010P | 2010-12-08 | 2010-12-08 | |
| PCT/EP2011/006091 WO2012076148A1 (en) | 2010-12-08 | 2011-12-06 | Systems and methods for automatically displaying patterns in biological monitoring data |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2649544A1 true EP2649544A1 (en) | 2013-10-16 |
Family
ID=45315721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP11794044.5A Ceased EP2649544A1 (en) | 2010-12-08 | 2011-12-06 | Systems and methods for automatically displaying patterns in biological monitoring data |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2649544A1 (en) |
| CN (1) | CN103229179B (en) |
| WO (1) | WO2012076148A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106413549B (en) | 2013-11-28 | 2019-09-24 | 豪夫迈·罗氏有限公司 | For analyzing the method and apparatus method, system and computer program product for the physiological measure of user being continuously monitored |
| US9465917B2 (en) * | 2014-05-30 | 2016-10-11 | Roche Diabetes Care, Inc. | Hazard based assessment patterns |
| PL3327598T3 (en) * | 2016-11-25 | 2025-10-20 | F. Hoffmann-La Roche Ag | A system and a method for automatically analyzing continuous glucose monitoring data indicative of glucose level in a bodily fluid |
| CN109276258B (en) * | 2018-08-10 | 2021-08-03 | 北京大学深圳研究生院 | Blood glucose trend prediction method, system and medical equipment based on DTW |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6925389B2 (en) * | 2000-07-18 | 2005-08-02 | Correlogic Systems, Inc., | Process for discriminating between biological states based on hidden patterns from biological data |
| US20040142403A1 (en) * | 2001-08-13 | 2004-07-22 | Donald Hetzel | Method of screening for disorders of glucose metabolism |
| US20100174553A1 (en) * | 2008-12-24 | 2010-07-08 | Medtronic Minimed, Inc. | Diabetes Therapy Management System |
-
2011
- 2011-12-06 WO PCT/EP2011/006091 patent/WO2012076148A1/en not_active Ceased
- 2011-12-06 CN CN201180058988.1A patent/CN103229179B/en active Active
- 2011-12-06 EP EP11794044.5A patent/EP2649544A1/en not_active Ceased
Non-Patent Citations (2)
| Title |
|---|
| None * |
| See also references of WO2012076148A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103229179A (en) | 2013-07-31 |
| WO2012076148A1 (en) | 2012-06-14 |
| CN103229179B (en) | 2016-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6882227B2 (en) | Systems and methods for processing analytical data and generating reports | |
| US11676734B2 (en) | Patient therapy management system that leverages aggregated patient population data | |
| CN114207737A (en) | System for biological monitoring and blood glucose prediction and associated methods | |
| US10867012B2 (en) | Data analytics and insight delivery for the management and control of diabetes | |
| US20160029931A1 (en) | Method and system for processing and analyzing analyte sensor signals | |
| Pérez-López et al. | Assessing motor fluctuations in Parkinson’s disease patients based on a single inertial sensor | |
| Jeon et al. | Predicting glycaemia in type 1 diabetes patients: experiments in feature engineering and data imputation | |
| WO2017035024A1 (en) | Data analytics and insight delivery for the management and control of diabetes | |
| US11998321B2 (en) | System and a method for automatically managing continuous glucose monitoring measurements indicative of glucose level in a bodily fluid | |
| CN103229179B (en) | Systems and methods for automatically revealing patterns in biomonitoring data | |
| Elgammal et al. | Digital twins in healthcare: a review of AI-powered practical applications across health domains | |
| US12243651B2 (en) | Systems and methods for automatically displaying patterns in biological monitoring data | |
| Kasl et al. | Utilizing wearable device data for syndromic surveillance: A fever detection approach | |
| Ferrara et al. | Personalizing seizure detection for individual patients by optimal selection of eeg signals | |
| Shao et al. | Air Traffic Controller Workload Detection Based on EEG Signals | |
| Coluzzi et al. | Multi-scale evaluation of sleep quality based on motion signal from unobtrusive device | |
| CN121263852A (en) | System and method for continuous glucose monitoring result prediction | |
| Islam et al. | Characterization of RAP signal patterns, temporal relationships, and artifact profiles derived from intracranial pressure sensors in acute traumatic neural injury | |
| HK1187995B (en) | Systems and methods for automatically displaying patterns in biological monitoring data | |
| HK1187995A (en) | Systems and methods for automatically displaying patterns in biological monitoring data | |
| Milbourn et al. | Wearable Technology and Machine Learning for Prediction of Performance-Based and Patient-Reported Outcome Measures: A Systematic Review | |
| HK40114895A (en) | A system and a method for automatically analyzing continuous glucose monitoring data | |
| Park et al. | PDSRS-LD: Personalized Deep Learning-Based Sleep Recommendation System Using Lifelog Data | |
| Boudabous et al. | Combining Signals for EEG-Free Arousal Detection during Home Sleep Testing: A Retrospective Study | |
| CN121002582A (en) | Computer-based methods, data processing systems, and applications for predicting glucose levels. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20130708 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ROCHE DIABETES CARE GMBH Owner name: F.HOFFMANN-LA ROCHE AG |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20180514 |
|
| APBK | Appeal reference recorded |
Free format text: ORIGINAL CODE: EPIDOSNREFNE |
|
| APBN | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2E |
|
| APBR | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3E |
|
| APAV | Appeal reference deleted |
Free format text: ORIGINAL CODE: EPIDOSDREFNE |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
| APBT | Appeal procedure closed |
Free format text: ORIGINAL CODE: EPIDOSNNOA9E |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
| 18R | Application refused |
Effective date: 20230203 |